News

CardioNXT, a privately-held medical device company, announced that it has secured an additional $2.1M in equity funding from a group of investors led by James W. Bullock and William A. Hawkins, III.  Piedmont Capital Partners and...

According to a new series of reports on the Australia market for patient monitoring equipment by iData Research (www.idataresearch.com), some hospitals in the region cannot afford high-cost monitoring platforms due to budget constraints....

Boehringer Ingelheim Pharmaceuticals, Inc. announced results from the first real-world, matched head-to-head study comparing all-cause healthcare costs and healthcare resource utilization (HCRU) among novel oral anticoagulants (NOACs). This...

A new Medtronic plc study shows a high use of app-based remote cardiac monitoring among older patients. Presented at Heart Rhythm 2017, the Heart Rhythm Society's 38th Annual Scientific Sessions, the first-of-its-kind study evaluated 15,595...

Holographic cardiac imaging and other innovations will be showcased at the EHRA EUROPACE – CARDIOSTIM 2017 in Vienna, Austria. This joint meeting of the European Heart Rhythm Association (EHRA), a registered branch of the European Society of...

Results published in the European Heart Journal show BIOTRONIK Home Monitoring® reduces the risk of all-cause mortality in ICD patients after one year by 38 percent. The TRUECOIN study also found a 36 percent reduction in the combined risk of...

Boston Scientific announced results from the U.S. post-market approval study evaluating 'real-world' patients implanted with the Subcutaneous Implantable Defibrillator (S-ICD) System, the largest S-ICD study to date. Data collected from the...

Congenital heart disease (CHD) includes a range of defects that occur in the heart which patients are born with, such as a hole in the heart’s wall, a leaky valve or even an inversion in the heart’s orientation. CHD was once a severe...

Medtronic plc announced new data supporting the clinical performance of the company's exclusive EffectivCRT(TM) Diagnostic and AdaptivCRT(TM) algorithm in heart failure patients who receive cardiac resynchronization therapy (CRT) devices. The...

Biosense Webster, Inc., part of the Johnson & Johnson Medical Devices Companies*, recently announced clinical trial results from a first-in-human study evaluating the acute feasibility of an investigational radiofrequency (RF) balloon...